| Page properties | ||||
|---|---|---|---|---|
|
Descriptions:
| Term | description type | Language/acceptability | Language/acceptability | Case significance |
|---|---|---|---|---|
At [qualifier] risk of [event or finding] (finding) | FSN | us:P | gb:P | ci |
At [qualifier] risk of [event or finding] | SYN | us:P | gb:P | ci |
Concept model:
| Attribute Group Cardinality | Attribute Cardinality | Attribute in Group Cardinality | Attribute | Value | ||||
|---|---|---|---|---|---|---|---|---|
| 0..0 | 1..1 |
|
| |||||
| 0..1 | 1..1 | 1..1 |
|
| ||||
| 0..1 | 1..1 | 1..1 |
|
| ||||
| 1..1 | 1..1 | 1..1 |
|
| ||||
| 1..1 | 1..1 |
|
| |||||
| 0..1 | 0..1 | 1..1 |
|
| ||||
| 0..1 | 1..1 |
|
|
Definition status:
| Scg expression |
|---|
900000000000073002|Defined (core metadata concept)| |
Applies to:
| Scg expression |
|---|
<<281694009 |Finding of at risk (finding)| |
Template Language
| Scg expression |
|---|
404684003 |Clinical finding (finding)|:
[[~0..1]] {[[~1..1]] 42752001 |Due to (attribute)| = [[+id (<<404684003 |Clinical finding (finding)|)]]},
[[~0..1]] {[[~1..1]] 719722006 |Has realization (attribute)| = [[+id (< 404684003 |Clinical finding (finding)| OR <272379006 |Event (event)|)]]},
[[~1..1]] {
[[~1..1]] 363714003 |Interprets (attribute)| = [[+id (1255619009 |Risk level (observable entity)|)]],
[[~1..1]] 363713009 |Has interpretation (attribute)| = [[+id (<<272520006 |Degree findings (qualifier value)|)]]}
[[~0..1]] {
[[~0..1]] 246454002 |Occurrence (attribute)| = [[+id(<<282032007 |Periods of life (qualifier value)|)]],
[[~0..1]] 246075003 |Causative agent (attribute)| = [[+id (< 105590001 |Substance (substance)|)]]} |
Link to the misaligned concept report
Overdose misaligned concept report 2021-Dec-14
Rules for generating descriptions:
Editorial guidelines for selection of Causative agent attribute value:
The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.
...
Example:
- 295184007 |Morphine overdose (disorder)|
...
Concepts representing substance modifications are exceptions and may be included if the overdose profile is significantly different from the substance base.
Exception examples:
- Liposome or lipid complex substances (e.g. 412088006 |Amphotericin B liposome (substance)|, 426490000 |Vincristine liposome (substance)|)
- Pegylated substance (e.g. 385544005 |Pegfilgrastim (substance)|, 770965008 |Pegvaliase (substance)|)
- Salt forms (e.g. 273948005 |Chloral hydrate (substance)|, 396063006 |Fluphenazine decanoate (substance)|)
Example:
- 296136008 |Chloral hydrate overdose (disorder)|
- 296213007 |Fluphenazine decanoate overdose (disorder)|
...
Overdose concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.
Example:
- 297053006 |Overdose of angiotensin-converting-enzyme inhibitors (disorder)|
- 296515004 |Opiate antagonist overdose (disorder)|
...
Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release.
Example:
- 297006008 |Diuretic overdose (disorder)|
- 295217003 |Non-steroidal anti-inflammatory overdose (disorder)|
...
Overdose concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.
Example:
- 295188005 |Pethidine analog overdose (disorder)|
- 1155996000 |Phenothiazine and/or phenothiazine derivative overdose (disorder)|
...
Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release.
...
...
The following types of groupers are out of scope; existing concepts have been inactivated or will be addressed in future release:
- Groupers based on more than one role (e.g. 292722006 |Chelating agents and antidotes adverse reaction (disorder)|)
- Groupers based on body system or intended site or route of administration (e.g. 292548001 |Drug groups primarily affecting respiratory system adverse reaction (disorder)|) or 417895009 |Topical agent adverse reaction (disorder)|)
- Groupers based on disposition, role, or structure combined with an individual substance (e.g. 287177000 |Sulfonamide/trimethoprim reaction (disorder)| or 292513008 |Methyldopa and diuretic adverse reaction (disorder)|)
- Groupers based on "combined" or "compound" substances (e.g. 292983008 |Combined penicillin preparation adverse reaction (disorder)| or 293358005 |Compound iron preparations adverse reaction (disorder)|)
- Groupers based on disposition or structure combined with intended site or route of administration (e.g. 433494006 |Adverse effect of oral diphosphonate (disorder)|)
Rules for description generation:
- For the FSN, align terming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.
- For the PT, align terming and case sensitivity with the US and GB PT for the concept that is selected as the attribute value.
- In cases where neither the US or GB PT matches the FSN, excluding the semantic tag, a synonym corresponding to the FSN is required unless explicitly identified as an exception.
JIRA ticket for implementation:
...